1-4 of 4
Buddha Gurung
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Leveraging Stage-Specific Promoters to Enhance Immune Cell Engineering in iPSC-Derived Cells for Cancer Immunotherapy

Arina Perez, Matthew S Hall, Sumei Lu, Brad Peterka, Michael Naso, Hy Levitsky, Buddha Gurung
Journal: Blood
Blood (2024) 144 (Supplement 1): 4820.
https://doi.org/10.1182/blood-2024-210942
Published: 2024
Journal Articles

Natural Killer and Gamma Delta T Cells Derived from Engineered Induced Pluripotent Stem Cells Have Potent Preclinical Activity to Treat B Cell-Mediated Autoimmune Diseases

Diana Chin, Andriana Lebid, Kaitlin Idank, Mark Mendonca, Arina Perez, Nicholas Alexander, Steven DeLuca, Charles Dominick, Buddha Gurung, Barry Morse, Liam Campion, Daniel Perry, Michael Naso, Hy Levitsky, Hillary Quinn
Journal: Blood
Blood (2024) 144 (Supplement 1): 3437.
https://doi.org/10.1182/blood-2024-210234
Published: 2024
Journal Articles

Development of Multi-Engineered iPSC-Derived CAR-NK Cells for the Treatment of B-Cell Malignancies

Luis Borges, Mark A Wallet, Chiamin-Liao Bullaughey, Michael F Naso, Buddha Gurung, Shelby Keating, Jill M Carton, John C Wheeler, Liam Campion, Mark Mendonca, Heidi K Jessup, Marilda Beqiri, Diana Chin, Hillary Millar Quinn, Barry A Morse
Journal: Blood
Blood (2021) 138 (Supplement 1): 1729.
https://doi.org/10.1182/blood-2021-148438
Published: 2021
Journal Articles

Bispecific and split CAR T cells targeting CD13 and TIM3 eradicate acute myeloid leukemia

Xin He, Zijie Feng, Jian Ma, Sunbin Ling, Yan Cao, Buddha Gurung, Yuan Wu, Bryson W. Katona, Kienan P. O’Dwyer, Don L. Siegel, Carl H. June, Xianxin Hua
Journal: Blood
Blood (2020) 135 (10): 713–723.
https://doi.org/10.1182/blood.2019002779
Published: 2020
Includes: Supplemental data